The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese (Q36031170)

11 August 2017

The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese (English)

1 reference

11 August 2017

0 references

Ming-Chia Hsieh

1

1 reference

11 August 2017

Tzu-Chi Lee

2

1 reference

11 August 2017

Shu-Min Cheng

3

1 reference

11 August 2017

Shih-Te Tu

4

1 reference

11 August 2017

Ming-Hong Yen

5

1 reference

11 August 2017

Chin-Hsiao Tseng

6

1 reference

11 August 2017

language of work or name

1 reference

5 June 2012

1 reference

Experimental Diabetes Research

11 August 2017

1 reference

11 August 2017

2012

1 reference

11 August 2017

413782

1 reference

Creative Commons Attribution 3.0 Unported

11 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Pioglitazone and bladder cancer: a population-based study of Taiwanese.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Diabetes and risk of prostate cancer: a study using the National Health Insurance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

2 October 2017

Cancer trends in Taiwan.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Association of diabetes with prostate cancer risk in the multiethnic cohort

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Insulin and insulin-like growth factor signalling in neoplasia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Managing type 2 diabetes: going beyond glycemic control

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Men: good health and high mortality. Sex differences in health and aging

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Diabetes mellitus and risk of breast cancer: a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Diabetes mellitus and risk of bladder cancer: a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

2 October 2017

Oral Antidiabetic Agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

The sex differential in morbidity, mortality, and lifestyle

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Sex differences in the incidence of tumours at various sites

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Sex differentials in cancer mortality and morbidity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan

11 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F413782

Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F413782

Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F413782

Prevention of pancreatic cancer induction in hamsters by metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F413782

Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F413782

Fasting serum glucose level and cancer risk in Korean men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F413782

Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F413782

Diabetes and the risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F413782

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F413782

Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F413782

What gender differences in cancer incidence changed during the last 10 years in central Italy?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374948

History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study

23 September 2018

1 reference

12 December 2020

Social sexual inequality and sex difference in cancer incidence

1 reference

12 December 2020

1 reference

12 December 2020

Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan

1 reference

12 December 2020

The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients

1 reference

12 December 2020

Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study

1 reference

12 December 2020

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

1 reference

12 December 2020

Mortality and causes of death in a national sample of diabetic patients in Taiwan

1 reference

12 December 2020

Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen

1 reference

12 December 2020

Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus

1 reference

12 December 2020

HUMAN MAMMARY SLICES IN ORGAN CULTURE. I. METHOD OF CULTURE AND PRELIMINARY OBSERVATIONS ON THE EFFECT OF INSULIN

1 reference

12 December 2020

Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study

1 reference

12 December 2020

Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan

1 reference

12 December 2020

A meta-analysis of diabetes mellitus and the risk of prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/413782

1 reference

11 August 2017

1 reference

11 August 2017

1 reference